These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 26635489)

  • 1. Evaluation of the impact of viscosity, injection volume, and injection flow rate on subcutaneous injection tolerance.
    Berteau C; Filipe-Santos O; Wang T; Rojas HE; Granger C; Schwarzenbach F
    Med Devices (Auckl); 2015; 8():473-84. PubMed ID: 26635489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Phase I Study to Assess the Effect of Speed of Injection on Pain, Tolerability, and Pharmacokinetics After High-volume Subcutaneous Administration of Gantenerumab in Healthy Volunteers.
    Portron A; Jordan P; Draper K; Muenzer C; Dickerson D; van Iersel T; Hofmann C
    Clin Ther; 2020 Jan; 42(1):108-120.e1. PubMed ID: 31883703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerability of High-Volume Subcutaneous Injections of a Viscous Placebo Buffer: A Randomized, Crossover Study in Healthy Subjects.
    Dias C; Abosaleem B; Crispino C; Gao B; Shaywitz A
    AAPS PharmSciTech; 2015 Oct; 16(5):1101-7. PubMed ID: 25693652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Injection Speed, Volume, and Site on Pain Sensation.
    Zijlstra E; Jahnke J; Fischer A; Kapitza C; Forst T
    J Diabetes Sci Technol; 2018 Jan; 12(1):163-168. PubMed ID: 28990437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of injection speed and volume on perceived pain during subcutaneous injections into the abdomen and thigh: a single-centre, randomized controlled trial.
    Heise T; Nosek L; Dellweg S; Zijlstra E; Præstmark KA; Kildegaard J; Nielsen G; Sparre T
    Diabetes Obes Metab; 2014 Oct; 16(10):971-6. PubMed ID: 24720741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enabling faster subcutaneous delivery of larger volume, high viscosity fluids.
    Rini CJ; Roberts BC; Vaidyanathan A; Li A; Klug R; Sherman DB; Pettis RJ
    Expert Opin Drug Deliv; 2022 Sep; 19(9):1165-1176. PubMed ID: 36053114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pain assessment of subcutaneous injections.
    Jørgensen JT; Rømsing J; Rasmussen M; Møller-Sonnergaard J; Vang L; Musaeus L
    Ann Pharmacother; 1996; 30(7-8):729-32. PubMed ID: 8826549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation of large volume subcutaneous injection tissue effects, pain, and acceptability in healthy adults.
    Woodley WD; Morel DR; Sutter DE; Pettis RJ; Bolick NG
    Clin Transl Sci; 2022 Jan; 15(1):92-104. PubMed ID: 34268888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel cannula design improves large volume auto-injection rates for high viscosity solutions.
    Roberts BC; Rini C; Klug R; Sherman DB; Morel D; Pettis RJ
    Drug Deliv; 2022 Dec; 29(1):43-51. PubMed ID: 34962225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Innovative Needle-free Injection System: Comparison to 1 ml Standard Subcutaneous Injection.
    Kojic N; Goyal P; Lou CH; Corwin MJ
    AAPS PharmSciTech; 2017 Nov; 18(8):2965-2970. PubMed ID: 28462463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding Subcutaneous Tissue Pressure for Engineering Injection Devices for Large-Volume Protein Delivery.
    Doughty DV; Clawson CZ; Lambert W; Subramony JA
    J Pharm Sci; 2016 Jul; 105(7):2105-13. PubMed ID: 27287520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel needle for subcutaneous injection of interferon beta-1a: effect on pain in volunteers and satisfaction in patients with multiple sclerosis.
    Jaber A; Bozzato GB; Vedrine L; Prais WA; Berube J; Laurent PE
    BMC Neurol; 2008 Oct; 8():38. PubMed ID: 18845005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Investigation of Large Volume Subcutaneous Delivery up to 25 mL for Lean and Non-Lean Subjects.
    Dang X; Shih H; Sharma R; Angwin-Kaerner DT; Lin K; Kapur S; Thyagarajapuram NR; Shi GH; Collins DS
    Pharm Res; 2024 Apr; 41(4):751-763. PubMed ID: 38443633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of performance, safety, subject acceptance, and compliance of a disposable autoinjector for subcutaneous injections in healthy volunteers.
    Berteau C; Schwarzenbach F; Donazzolo Y; Latreille M; Berube J; Abry H; Cotten J; Feger C; Laurent PE
    Patient Prefer Adherence; 2010 Oct; 4():379-88. PubMed ID: 21049090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of injection speed on pain during injection of local anaesthetic.
    Tangen LF; Lundbom JS; Skarsvåg TI; Wågø KJ; Ballo S; Hjelseng T; Finsen V
    J Plast Surg Hand Surg; 2016; 50(1):7-9. PubMed ID: 26414074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased injection pain with darbepoetin-alpha compared to epoetin-beta in paediatric dialysis patients.
    Schmitt CP; Nau B; Brummer C; Rosenkranz J; Schaefer F
    Nephrol Dial Transplant; 2006 Dec; 21(12):3520-4. PubMed ID: 16935904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcutaneous injection pain with C.E.R.A., a continuous erythropoietin receptor activator, compared with darbepoetin alfa.
    Pannier A; Jordan P; Dougherty FC; Bour F; Reigner B
    Curr Med Res Opin; 2007 Dec; 23(12):3025-32. PubMed ID: 17961301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcutaneous Injection of Drugs: Literature Review of Factors Influencing Pain Sensation at the Injection Site.
    Usach I; Martinez R; Festini T; Peris JE
    Adv Ther; 2019 Nov; 36(11):2986-2996. PubMed ID: 31587143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Injection of acidic or neutral insulin and pain: a single-center, prospective, controlled, noninterventional study in pediatric patients with type 1 diabetes mellitus.
    Karges B; Muche R; Riegger I; Moritz M; Heinze E; Debatin KM; Wabitsch M; Karges W
    Clin Ther; 2006 Dec; 28(12):2094-101. PubMed ID: 17296465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immediate pain sensation is less with subcutaneous epoietin-beta compared to subcutaneous darbepoietin-alpha.
    Ter Wee PM; de Koter Y; van der Veer O; van Vliet MH
    Clin Nephrol; 2009 Sep; 72(3):177-80. PubMed ID: 19761721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.